health care costs

Clinical Pathways GPS

Population Health Delivery Through Health Systems and Pharma

09/06/2016

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

As health systems become more prevalent, they are having increasing levels of control over treatment decisions, in coordination with physicians and managed care organizations. As a result of this increased level of...

As...

09/06/2016

Journal of Clinical Pathways

Interview

How Financial Distress Can Affect Cancer Care

09/06/2016

Christopher S Lathan, MD, MS, MPH

An interview with Christopher S Lathan, MD, MS, MPH, assistant professor of medicine, Harvard Medical School; faculty director, Cancer Care Equity Program; medical director, Dana-Farber Cancer Institute at St...

An...

09/06/2016

Journal of Clinical Pathways

The Payer Perspective

08/02/2016

JCP Editors

Balancing out the provider perspective was Andrew Allan  Hertler, MD, FACP, New Century Health, who explained why clinical pathways are increasingly being used by payers as a tool for controlling oncology...

...

08/02/2016

Journal of Clinical Pathways

Interview

Reducing Waste in Oncology Drug Use

06/20/2016

  According to a recent report, prescription drug costs rose by more than 12% in 2014 and are expected to continue to rise by more than 7% through 2018.1 In addition, a study of the out-of-pocket costs...

...

06/20/2016

Journal of Clinical Pathways

Research in Review

Bundled Payments Model Utilizing Clinical Pathways a Success for Hip and Knee Replacements

06/20/2016

JCP Editors

A Bundled Payments for Care Improvement model developed at New York University Langone Medical Center (NYULMC), New York City, NY, was successful at improving institutional efficiency and providing more value...

...

06/20/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Hitting Each Component of the Triple Aim Along the Clinical Pathway

05/06/2016

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Scott Guerin, PhD

Seth Gordon, MBA

The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...

The...

05/06/2016

Journal of Clinical Pathways

Research in Review

Elements for Successful Clinical Pathway Development and Maintenance Identified

05/06/2016

JCP Editors

As pathways become more ingrained in the everyday care of patients with various diseases, Andrew R Bunchert, MD, and Gabriella A Butler, MSN, RN, health care professionals at the Children’s Hospital of Pittsburgh...

As...

05/06/2016

Journal of Clinical Pathways

Research in Review

Increasing Use of Percutaneous Liver Biopsy Accompanied by Growing Costs

05/06/2016

JCP Editors

A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as rising...

...

05/06/2016

Journal of Clinical Pathways

Research in Review

Clinical Pathways Improve Outcomes and Decrease Costs in Pediatric Care

05/06/2016

JCP Editors

The implementation of evidence-based, standardized clinical pathways may be an effective way of maintaining high-quality care at lower costs in pediatric care settings, results of a recent study show.  Clinical...

The...

05/06/2016

Journal of Clinical Pathways

Editor's Page

For Buy-In of the Clinical Pathways Concept, Transparency Is Key

05/06/2016

Winston Wong, PharmD, Editor-in-Chief

Essential to the success of clinical pathways is transparency of the development process. This includes transparency regarding the clinical evidence reviewed, the economic evaluations made, and the process by which...

...

05/06/2016

Journal of Clinical Pathways